Inceptiv is a small device, implanted in the lower torso with leads to the spinal cord, that provides responsive counter-stimulation to relieve chronic pain. The device was approved by the FDA in ...

Tivic Health has completed enrolment in a study being conducted to finetune its non-invasive vagus nerve stimulation (VNS) ...

Nevro's HFX iQ spinal cord stimulator earned the European Union's CE mark, the company said Nov. 12. HFX iQ has already earned FDA approval in 2022, according to a news release. The spinal cord ...

Medtronic devices) with modern SCS systems. The researchers concluded, “Although SCS and DRG stimulation are well-established and safe treatment for chronic pain, the long-term explantation risk ...

Finally, the researchers note that it may not be appropriate, in some cases, to compare traditional technologies (eg, Medtronic devices) with modern SCS systems. The researchers concluded, “Although ...

The global spinal cord stimulators market is on a robust growth trajectory, poised to reach an impressive valuation of USD 5,441.4 million by 2033. Currently valued at USD 2,702.7 million in 2023, the ...

NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

He originally joined Medtronic in 1991 with the title of ... It plans to launch its ARC-EX spinal cord stimulation in the U.S. later this year. In addition to the ARC-EX, Onward develops the ...

Medtronic makes the device that Kim received ... signal that is delivered to the spinal cord. Hence the term spinal cord stimulator," says Dr. White. "It's minor surgical pain afterwards, it ...